GentaSoothe description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

GentaSoothe

Teva Animal Health, Inc.
American Pharmaceuticals and Cosmetics, Inc.

GentaSoothe Topical Spray


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Front Panel Label

GentaSoothe
Topical Spray

(Gentamicin Sulfate With
Betamethasone Valerate)

Veterinary

CAUTION: Federal Law restricts this drug
to use by or on the order of a
licensed veterinarian

ANADA 200-388, Approved by FDA

Net Contents: 120 mL

TEVA

Teva Animal Health, Inc.

Each mL contains:








For topical use in dogs only.
For animal use only.
Keep out of Reach of Children.

Usual dose:


Read accompanying directions carefully.
00
00




Chemistry, Pharmacology and Toxicity

PRODUCT INFORMATION


GENTAMICIN SULFATE WITH BETAMETHASONE
VALERATE TOPICAL SPRAY




Veterinary
For Topical Use in Dogs Only
For Animal Use Only

Caution:


DESCRIPTION:







CHEMISTRY:

Micromonospora purpures









PHARMACOLOGY:





1,2

Alcaligenes sp., Citrobacter sp.,
Klebsiella sp., Pseudomonas aeruginosa,

Proteus sp., Escherichia
coli, Enterobacter sp., Staphylococcus sp. and
Streptococcus sp.




3











TOXICITY:












WARNING

WARNING:









INDICATIONS AND CONTRAINDICATIONS

INDICATIONS: For the treatment of infected superficial lesions in dogs
caused by bacteria susceptible to gentamicin.

CONTRAINDICATIONS: If hypersensitivity of any of the components
occurs, discontinue treatment and institute appropriate therapy.

GENTASOOTHE DOSAGE AND ADMINISTRATION

DOSAGE AND ADMINISTRATION: Prior to treatment, remove excessive
hair and clean the lesion and adjacent area. Hold bottle upright 3 to 6
inches from the lesion and depress the sprayer head twice. Administer 2
to 4 times daily for 7 days.

Each depression of the sprayer head delivers 0.7 mL of Gentamicin
Sulfate With Betamethasone Valerate Topical Spray.

SIDE EFFECTS AND PRECAUTIONS

SIDE EFFECTS: Side effects such as SAP and SGPT enzyme
elevations, weight loss, anorexia, polydipsia and polyuria have occurred
following parenteral or systemic use of synthetic corticosteroids in dogs.
Vomiting and diarrhea (occasionally bloody) have been observed in dogs.

Cushing's syndrome in dogs has been reported in association with
prolonged or repeated steroid therapy.

PRECAUTIONS: Antibiotic susceptibility of the pathogenic organism(s)
should be determined prior to use of this preparation. Use of topical
antibiotics may permit overgrowth of non-susceptible bacteria, fungi or
yeasts. If this occurs, treatment should be instituted with other
appropriate agents as indicated.

Administration of recommended dose beyond 7 days may result in
delayed wound healing. Animals treated longer than 7 days should be
monitored closely.

Avoid ingestion. Oral or parenteral use of corticosteroids, depending on
dose, duration and specific steroid may result in inhibition of endogenous
steroid production following drug withdrawal.

In patients presently receiving or recently withdrawn from systemic
corticosteroids treatments, therapy with a rapidly acting corticosteroid
should be considered in especially stressful situations.

If ingestion should occur, patients should be closely observed for the
usual signs of adrenocorticoid overdosage, which includes sodium
retention, potassium loss, fluid retention, weight gains, polydipsia and/or
polyuria. Prolonged use or overdosage may produce adverse
immunosuppressive effects.

HOW SUPPLIED AND STORAGE

HOW SUPPLIED: Plastic spray bottles containing 60 mL,
and 120 mL of Gentamicin Sulfate with Betamethasone Valerate Topical Spray.

Store upright between 20C and 300C (360F and 860F).

REFERENCES


REFERENCES:

1. Hennessy, PW, et al. In vitro activity of gentamicin against bacteria
isolated from domestic animals.  Veterinary Medicine/Small Animal
Clinician
. November 1971; 1118-1122.

2. Bachmann, HJ, et al. Comparative in vitro activity of gentamicin and
other antibiotics against bacteria isolated from clincial samples from
dogs, cats, horses and cattle. Veterinary Medicine/Small Animal
Clinician
. October 1975; 1218-1222.

3. McKenzie, HW and Atkinson, RM. Topical activities of betamethasone
esters in Man. Arch Derm. May 1964;741-746.

Manufactured for                                                Iss1110
Teva Animal Health, Inc.
St. Joseph, MO 64503

Bottle Label Image

Bottle Label Image

GentaSoothe

Front Onsert Image

Front Onsert Image

GentaSoothe

Back Onsert Image

Back Onsert Image

GentaSoothe

GS Dozen Box Image

GS Dozen Box Image

GentaSoothe

GentaSoothe

Gentamicin sulfate and betamethasone valerate SPRAY

Product Information

Product Type Prescription animal drug label Item Code (Source) NDC:59130-635
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Gentamicin Sulfate GENTAMICIN 0.57 mg
BETAMETHASONE VALERATE BETAMETHASONE 0.284 mg

Inactive Ingredients

Ingredient Name Strength
ISOPROPYL ALCOHOL
propylene glycol
METHYLPARABEN
PROPYLPARABEN
water

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 60 in 1 BOTTLE, SPRAY
2 120 in 1 BOTTLE, SPRAY
3 NDC:59130-635-07 12 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANADA ANADA200388 2011-03-14


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.